Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy

Diabetes Care

Volumn 20, Issue 12, 1997, Pages 1896-1899

  Shigeta, Hirofumi ^b   Yamaguchi, Makiko ^b   Nakano, Koji ^b   Obayashi, Hiroshi ^c   Takemura, Reiji ^b   Fukui, Michiaki ^b   Fujii, Mitsuhiro ^b   Yoshimori, Kuniaki ^b   Hasegawa, Goji ^b   Nakamura, Naoto ^b   Kitagawa, Yoshihiro ^a   Kondo, Motoharu ^b  

^a Osaka Gen Hosp W Japan Rlwy Co   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Kyoto Microbiological Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PHOSPHOLIPID ANTIBODY; SULFATIDE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; DIABETIC NEUROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MYELIN SHEATH; NERVE INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYNEUROPATHY; QUANTITATIVE ASSAY;

EID: 0030859890     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.12.1896     Document Type: Article

References (16)

1. Vinik AI, Liuzzi FJ, Holland MT, Stansberry KB, Le Beau JM, Colen LB: Diabetic neuropathies. Diabetes Care 15:1926-1975, 1992
2. American Diabetes Association, American Academy of Neurology: Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes Care 11:592-597, 1988
3. Dyck PJ: Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11:21-32, 1988
4. Goto Y, Hotta N, Shigeta Y, Sakamoto N, Kikkawa R: Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy: clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study. Biomed Pharmacother 49:269-277, 1995
5. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien P, Service FJ: Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 10:432-440, 1987
6. Harris EN, Gharavi AK, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GR: Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet ii:1211-1214, 1983
7. Buschard K, Josefsen K, Horn T, Fredman P: Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitus. Lancet 342:840, 1993
8. Buschard K, Josefsen K, Hansen SV, Horn T, Marshall MO, Persson H, Mansson J-E, Fredman P: Sulphatide in islets of Langerhans and in organs affected in diabetic late complications: a study in human and animal tissue. Diabetologia 37:1000-1006, 1994
9. Pestronk A, Li F, Griffin J, Feldman EL, Cornblath D, Trotter J, Zhu S, Yee WC, Phillips D, Peeples DM, Winslow B: Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 41:357-362, 1991
10. Quattrini A, Corbo M, Dhaliwal SK, Sadig SA, Lugaresi A, Oliveira A, Uncini A, Abouzahr K, Miller JR, Lewis L, Estes D, Cardo L, Hays AP, Latov N: Anti-sulfatide antibodies in neurological disease: binding to rat dorsal root ganglia neurons. J Neurol Sci 112:152-159, 1992
11. van den Berg LH, Lankamp CLAM, de Jager AEJ, Notermans NC, Sodaar P, Marrink J, deJong HJ, Bar PR, Wokke JH: Anti-sulphatide antibodies in peripheral neuropathy J Neurol Neurosurg Psychiatry 56:1164-1168, 1993
12. Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 84:2854-2867, 1994
13. Asherson RA: A "primary" antiphospholipid syndrome? J Rheumatol 15:1742-1746, 1988
14. Harris EN: Antiphospholipid antibodies. Br J Haematol 74:1-9, 1990
15. Vinik AI, Holland M, Leichter SB, Powers AC, Pittenger G, Suwanwalaikorn S, Stansberry KB: Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy. Diabetes Care 18:1225-1232, 1995
16. Pittenger GL, Liu D, Vinik AI: The neuronal toxic factor in serum of type 1 diabetic patients is a complement-fixing autoantibody. Diabet Med 12:380-386, 1995